Incyte (INCY), MorphoSys AG (MOR) Doses First Patient in Phase 3 inMIND Study
Go back to Incyte (INCY), MorphoSys AG (MOR) Doses First Patient in Phase 3 inMIND StudyIncyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 56.83 -0.29 (0.51%) | |||||
---|---|---|---|---|---|---|
Previous Close | $57.12 | 52 Week High | $118.49 | |||
Open | $57.25 | 52 Week Low | $55.00 | |||
Day High | $57.40 | P/E | N/A | |||
Day Low | $56.61 | EPS | $-0.56 | |||
Volume | 831,584 |
(AMEX: MDAX) | Delayed: 0.62 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.62 | 52 Week High | $ | |||
Open | $0.62 | 52 Week Low | $ | |||
Day High | $0.62 | P/E | N/A | |||
Day Low | $0.62 | EPS | $ | |||
Volume | 0 |
Morgan Stanley Capital Protected Notes for S&P 500 Index (NASDAQ: MOR) | Delayed: 18.12 -0.02 (0.11%) | |||||
---|---|---|---|---|---|---|
Previous Close | $18.14 | 52 Week High | $13.71 | |||
Open | $18.15 | 52 Week Low | $9.64 | |||
Day High | $18.16 | P/E | N/A | |||
Day Low | $18.10 | EPS | $0.00 | |||
Volume | 169,887 |